Optimal Two-Stage Designs Allowing Flexibility in Number of Subjects for Phase II Clinical Trials

Author: Masaki Nobuyuki  

Publisher: Taylor & Francis Ltd

ISSN: 1054-3406

Source: Journal of Biopharmaceutical Statistics, Vol.19, Iss.4, 2009-07, pp. : 721-731

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract